0001179110-22-000383.txt : 20220111
0001179110-22-000383.hdr.sgml : 20220111
20220111160905
ACCESSION NUMBER: 0001179110-22-000383
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220107
FILED AS OF DATE: 20220111
DATE AS OF CHANGE: 20220111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STEELE GLENN JR MD PHD
CENTRAL INDEX KEY: 0001269131
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 22523984
MAIL ADDRESS:
STREET 1: 250 TECHNOLOGY PARK
CITY: LAKE MARY
STATE: FL
ZIP: 32746-6232
FORMER NAME:
FORMER CONFORMED NAME: STEELE GLENN JR MD
DATE OF NAME CHANGE: 20031105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
edgar.xml
FORM 4 -
X0306
4
2022-01-07
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001269131
STEELE GLENN JR MD PHD
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
1
0
0
0
Common Stock
2022-01-07
4
A
0
3200
0
A
6500
D
Stock Option (Right To Buy)
38.10
2022-01-07
4
A
0
12000
0
A
2032-01-06
Common Stock
12000
12000
D
Restricted stock units granted on January 7, 2022 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2022 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 7, 2023. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death.
This option was granted on January 7, 2022 and vests over one year in twelve equal monthly installments, commencing on February 7, 2022.
/s/ Avraham S. Adler, attorney-in-fact
2022-01-11